These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30183204)

  • 21. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
    Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
    Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.
    Andrade GC; Fujise LH; Santana JE; Oliveira F; Silva Rde C
    Rev Assoc Med Bras (1992); 2016; 62(3):218-26. PubMed ID: 27310544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An apparent cluster of congenital hypopituitarism in central Massachusetts: magnetic resonance imaging and hormonal studies.
    Brown RS; Bhatia V; Hayes E
    J Clin Endocrinol Metab; 1991 Jan; 72(1):12-8. PubMed ID: 1846002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe.
    Melo ME; Marui S; Carvalho LR; Arnhold IJ; Leite CC; Mendonça BB; Knoepfelmacher M
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):95-102. PubMed ID: 17201807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypopituitarism presenting as a mixed hyperlipidaemia.
    Kilpatrick ES; Patmore JE; Rowland-Hill C; Atkin SL
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):344-5. PubMed ID: 15298750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and growth in a woman with untreated hypothalamic panhypopituitarism of 21 years' duration.
    Tolis G; Cruess S; Goldstein M; Friesen HG; Rochefort JG
    Can Med Assoc J; 1974 Sep; 111(6):553-6. PubMed ID: 4370418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Craniopharyngioma presenting with severe hyponatremia, hyponatremia-induced myopathy, and panhypopituitarism: a case report.
    Dilrukshi MD; Sandakumari GV; Abeysundara PK; Chang T
    J Med Case Rep; 2017 Feb; 11(1):31. PubMed ID: 28160775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypopituitarism in the elderly.
    Antonopoulou M; Sharma R; Farag A; Banerji MA; Karam JG
    Maturitas; 2012 Aug; 72(4):277-85. PubMed ID: 22727068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas.
    Auer MK; Stalla GK; Stieg MR
    Pituitary; 2016 Oct; 19(5):461-71. PubMed ID: 27194386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy and other pituitary disorders (including GH deficiency).
    Karaca Z; Kelestimur F
    Best Pract Res Clin Endocrinol Metab; 2011 Dec; 25(6):897-910. PubMed ID: 22115165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible endocrine dysfunction and pituitary stalk enlargement.
    Chico A; Puig-Domingo M; Martul P; De Juan M; Prats JM; Mauricio D; Webb SM
    J Endocrinol Invest; 1998 Feb; 21(2):122-7. PubMed ID: 9585387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypopituitarism].
    Imura H; Kato Y; Nakai Y
    Nihon Rinsho; 1986 Mar; 44(3):678-88. PubMed ID: 3525899
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective study.
    Kessoku T; Yoneda M; Sumida Y; Eguchi Y; Fujii H; Hyogo H; Ono M; Kawaguchi T; Nakajima A;
    J Clin Gastroenterol; 2015 Feb; 49(2):169-70. PubMed ID: 25014241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.